Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats

被引:13
作者
Pees, C
Unger, T
Gohlke, P
机构
[1] Univ Kiel, Inst Pharmacol, D-24105 Kiel, Germany
[2] Humboldt Univ, Charite, Inst Pharmacol & Toxicol, Berlin, Germany
关键词
AT(1)receptor antagonist; AT(2) receptor; bradykinin; nitric oxide; cyclic GMP;
D O I
10.1016/S1357-2725(02)00265-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study in normotensive Wistar Kyoto rats (WKY), we investigated whether any angiotensin II (ANG II) increases in vascular cyclic GMP production were via stimulation of AT(2) receptors. Adult WKY were infused for 4 h with ANG II (30 ng/kg per min, i.v.) or vehicle (0.9% NaCl, i.v.) after pretreatment with (1) vehicle, (2) losartan (100 mg/kg p.o.), (3) PD 123319 (30 mg/kg i.v.), (4) losartan + PD 123319, (5) icatibant (500 mug/kg i.v.), (6) L-NAME (1 mg/kg i.v.), (7) minoxidil (3 mg/kg i.v.). Mean arterial blood pressure (MAP) was continuously monitored, and plasma ANG II and aortic cyclic GMP were measured at the end of the study. ANG II infusion over 4 h raised MAP by a mean of 13 mmHg. This effect was completely prevented by AT(1) receptor blockade. PD 123319 slightly attenuated the pressor effect induced by ANG II alone (123.4 +/- 0.8 versus 130.6 +/- 0.6) but did not alter MAP in rats treated simultaneously with ANG II + losartan (113 +/- 0.6 versus 114.3 +/- 0.8). Plasma levels of ANG II were increased 2.2-3.7-fold by ANG II infusion alone or ANG II in combination with the various drugs. The increase in plasma ANG II levels was most pronounced after ANG II + losanan treatment but absent in rats treated with losartan alone. Aortic cyclic GMP levels were not significantly changed by either treatment. Our results demonstrate that the AT(2) receptor did not contribute to the cyclic GMP production in the vascular wall of normotensive WKY. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:963 / 972
页数:10
相关论文
共 41 条
[1]   METABOLISM AND PRODUCTION OF ANGIOTENSIN-I IN DIFFERENT VASCULAR BEDS IN SUBJECTS WITH HYPERTENSION [J].
ADMIRAAL, PJJ ;
DERKX, FHM ;
DANSER, AHJ ;
PIETERMAN, H ;
SCHALEKAMP, MADH .
HYPERTENSION, 1990, 15 (01) :44-55
[2]   AT2 receptor stimulation enhances antihypertensive effect of AT1 receptor antagonist in hypertensive rats [J].
Barber, MN ;
Sampey, DB ;
Widdop, RE .
HYPERTENSION, 1999, 34 (05) :1112-1116
[3]   ENDOTHELIAL AT(1)-MEDIATED RELEASE OF NITRIC-OXIDE DECREASES ANGIOTENSIN-II CONTRACTIONS IN RAT CAROTID-ARTERY [J].
BOULANGER, CM ;
CAPUTO, L ;
LEVY, BI .
HYPERTENSION, 1995, 26 (05) :752-757
[4]   EFFECTS OF LOSARTAN ON ANGIOTENSIN AND BRADYKININ PEPTIDES AND ANGIOTENSIN-CONVERTING ENZYME [J].
CAMPBELL, DJ ;
KLADIS, A ;
VALENTIJN, AJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (02) :233-240
[5]   Responses to angiotensin peptides are mediated by AT1 receptors in the rat [J].
Champion, HC ;
Czapla, MA ;
Kadowitz, PJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (01) :E115-E123
[6]   Angiotensin II relaxes microvessels via the AT2 receptor and Ca2+-activated K+ (BKCa) channels [J].
Dimitropoulou, C ;
White, RE ;
Fuchs, L ;
Zhang, HF ;
Catravas, JD ;
Carrier, GO .
HYPERTENSION, 2001, 37 (02) :301-307
[7]   Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats [J].
Endo, Y ;
Arima, S ;
Yaoita, H ;
Tsunoda, K ;
Omata, K ;
Ito, S .
JOURNAL OF VASCULAR RESEARCH, 1998, 35 (06) :421-427
[8]   EFFECT OF LOW-DOSE TREATMENT WITH PERINDOPRIL ON CARDIAC-FUNCTION IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS - ROLE OF BRADYKININ [J].
GOHLKE, P ;
KUWER, I ;
BARTENBACH, S ;
SCHNELL, A ;
UNGER, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (03) :462-469
[9]   LONG-TERM LOW-DOSE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR TREATMENT INCREASES VASCULAR CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE [J].
GOHLKE, P ;
LAMBERTY, V ;
KUWER, I ;
BARTENBACH, S ;
SCHNELL, A ;
LINZ, W ;
SCHOLKENS, BA ;
WIEMER, G ;
UNGER, T .
HYPERTENSION, 1993, 22 (05) :682-687
[10]   AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism [J].
Gohlke, P ;
Pees, C ;
Unger, T .
HYPERTENSION, 1998, 31 (01) :349-355